- Companies
- Osso VR
Osso VR Funding, Investors & Competitors
Osso VR has raised $109M across 4 funding rounds, most recently a $66M Series C in March 2022.
Last Osso VR funding round
$66M
Series C · Mar 2022
Cumulative funding Osso VR raised
$109M
across 4 funding rounds
Key investors in Osso VR
SignalFire
GSR Ventures
Kaiser Permanente Ventures
OCA Ventures
Scrum Ventures
Anorak Ventures
Leslie Ventures
Tiger Global
About Osso VR
Osso VR is an Atlanta-headquartered virtual reality platform for surgical training. It features simulations of over 200 procedures across orthopedics, neurosurgery, and plastics using hand-tracking for realistic instrument handling, adopted by Mayo Clinic and Medtronic.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Osso VR Funding History
Osso VR has raised a total of $109M across 4 funding rounds.
Osso VR's first fundraising round was a $2M seed round in June 2017. The most recent completed round was a $66M Series C in March 2022.
Osso VR funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Mar 2022 | Series C | Oak HC/FT (lead); Kaiser Permanente Ventures; SignalFire; GSR Ventures; Tiger Global; Duro Ventures | $66M | Osso VR is a San Francisco-based startup founded in 2016 that develops a virtual reality (VR) platform for surgical training and assessment, enabling physicians to practice procedures in a virtual operating room. The platform offers high-fidelity modules for new and established surgical techniques, partnering with medical device companies like Johnson & Johnson, Stryker, Zimmer Biomet, and Smith + Nephew to train surgeons on their equipment. Most revenue derives from these companies based on the number of trainings conducted, though specific figures are not disclosed. On March 24, 2022, Osso VR raised $66 million in a Series C funding round led by Oak HC/FT, with participation from SignalFire, GSR Ventures, Tiger Global Management, and Kaiser Permanente Ventures. This brought total funding to approximately $109 million across prior rounds, including a $27 million Series B less than a year earlier. The investors matched the query's details, confirming the exact round. The proceeds will expand access to the training platform for healthcare professionals, scale beyond existing 120-150 modules into additional specialties like spine and interventional cardiology, and support significant hiring to double headcount to over 300 employees. Osso VR positions itself as the gold standard for surgical education, addressing steep learning curves in modern procedures and standardizing proficiency assessments lacking in traditional methods. The platform has seen rapid adoption accelerated by pandemic-driven telehealth trends, with medical device firms using it to reduce reliance on cadaver labs and travel. Peers focus narrowly on orthopedics, but Osso VR broadens across specialties, boasting the world's largest VR surgical training library at the time. |
| Jul 2021 | Series B | GSR Ventures (lead); Kaiser Permanente Ventures; SignalFire; Leslie Ventures; Anorak Ventures; OCA Ventures; Scrum Ventures; Bossa Invest | $27M | Osso VR is a San Francisco-based virtual reality surgical training and assessment platform that enables surgeons to practice procedures and learn new medical devices in immersive 3D environments. The platform runs on Facebook's Oculus Quest 2 headset and includes over 120 modules spanning more than 10 surgical specialties including orthopedics, endoscopy, and interventional procedures. The company was founded by Dr. Justin Barad, a UCLA and Harvard-trained orthopedic surgeon, and operates in more than 20 countries with partnerships across hospital residency programs and major medical device manufacturers including Johnson & Johnson, Stryker, and Smith & Nephew. On July 7, 2021, Osso VR announced it had secured $27 million in Series B funding led by GSR Ventures, with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures, and Anorak Ventures. This round came less than a year after the company's $14 million Series A led by Kaiser Permanente, bringing total funding to approximately $43 million at the time of the Series B announcement. The company stated the capital would be used to expand its VR content library and platform capabilities. At the time of the Series B, Osso VR had approximately 100 employees and was experiencing rapid growth driven by increased demand for virtual training during the COVID-19 pandemic. The company employed what it described as the world's largest team of medical illustrators and designed all virtual experiences in-house. CEO Dr. Barad emphasized the platform's clinical effectiveness and its unique ability to scale to millions of healthcare providers globally. The company went on to raise an additional $66 million in Series C funding led by Oak HC/FT in March 2022, demonstrating strong investor confidence in its mission to democratize surgical education and improve patient outcomes. |
| Sep 2020 | Series A | Kaiser Permanente Ventures (lead); SignalFire; Leslie Ventures; OCA Ventures; GSR Ventures; Scrum Ventures | $14M | Osso VR raised $14 million in a Series A funding round on September 21, 2020, led by Kaiser Permanente Ventures with participation from SignalFire, GSR Ventures, Scrum Ventures, Leslie Ventures, and OCA Ventures. The Palo Alto-based company develops a validated virtual reality platform for surgical training, used in over 20 teaching hospitals and 11 medical device companies across 20 countries. A recent validation study showed a 230% improvement in surgical performance from using the platform. The funding supports further development of the VR surgical training platform amid rising demand during the COVID-19 pandemic, as medical device manufacturers and healthcare networks seek remote training solutions without on-site technicians. Osso VR's adoption has skyrocketed, addressing challenges in procedural training and practice in medicine. The company, founded in 2016 by orthopedic surgeon Justin Barad, aims to improve patient outcomes, boost adoption of high-value medical technology, and democratize surgical education globally. This Series A brought Osso VR's total funding to $16 million following a $2 million seed round in 2017. |
| Jun 2017 | Seed | SignalFire (lead); MedTech Innovator; Anorak Ventures | $2M | - |
Who has invested in Osso VR?
12 investors have backed Osso VR across its funding rounds, including SignalFire, GSR Ventures, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures and Anorak Ventures.
Lead investors include Oak HC/FT, GSR Ventures, Kaiser Permanente Ventures and SignalFire.
Osso VR Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Jun 2017 | ||
| 3 | Lead | Sep 2020 | ||
| 3 | Lead | Sep 2020 | ||
| 2 | Participant | Sep 2020 | ||
| 2 | Participant | Jun 2017 | ||
| 2 | Participant | Sep 2020 | ||
| 2 | Participant | Sep 2020 | ||
| 1 | Participant | Jun 2017 | ||
| 1 | Lead | Mar 2022 | ||
| 1 | Participant | Mar 2022 | ||
This data is available for Pro users. Sign up to see all 12 Osso VR investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialOsso VR Competitors
Osso VR competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x | ||
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $7.9B | $3.2B | $37B | 5.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $400M | - | $6.4B | 16.0x |
Osso VR Public Comps
Osso VR is still privately-owned, but its public comps include Meta, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, BOE, GE HealthCare, Unity, ICON plc and Pro Medicus.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $201B | $104B | 8.8x | 7.4x | 17.0x | 12.7x | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $31B | $7B | 1.7x | 1.6x | 7.5x | 7.3x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $1.8B | ($18M) | 10.0x | 8.8x | (1025.6x) | 30.5x | |||
This data is available for Pro users. Sign up to see all Osso VR competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Osso VR
| When was Osso VR founded? | Osso VR was founded in 2016. |
| Where is Osso VR headquartered? | Osso VR is headquartered in San Francisco, CA, United States. |
| Is Osso VR publicly listed? | No, Osso VR is a private, VC-backed company. |
| How much funding has Osso VR raised? | Osso VR has raised $109M across 4 funding rounds. |
| What was Osso VR's last funding round? | Osso VR's last funding round was a $66M Series C in March 2022, led by Oak HC/FT. |
| Who are Osso VR's investors? | Osso VR's investors include SignalFire, Kaiser Permanente Ventures, GSR Ventures, Leslie Ventures, Anorak Ventures, OCA Ventures, Scrum Ventures, MedTech Innovator, Oak HC/FT, Tiger Global and 2 others. |
| Which companies are comparable to Osso VR? | Companies comparable to Osso VR include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib. |
See companies similar to Osso VR
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




